DIAKINE THERAPEUTICS
DiaKine Therapeutics, Inc. is a development stage company commercializing novel immune modulators for the treatment of diabetes and related complications. These drugs have the potential to stop the progression of diabetes and reverse damage already caused by the disease. Therapeutics under development by DiaKine include: adjunct therapy to islet cell transplants (in Phase 2 clinical trial), halting the progression of type 1 diabetes in newly diagnosed adults, treatment and prevention of Latent A... utoimmune Diabetes of Adults (LADA), treatment and prevention of insulin requiring type 2 diabetic, treatment and prevention of diabetes complications. DiaKine would like to thank the National Institute of Diabetes & Digestive & Kidney Diseases/National Institutes of Health (NIDDK/NIH) for producing the clinical trials supplies for the trial.
DIAKINE THERAPEUTICS
Industry:
Biopharma Biotechnology Pharmaceutical Therapeutics
Founded:
2004-01-01
Address:
Norfolk, Virginia, United States
Country:
United States
Website Url:
http://www.diakine.com
Total Employee:
251+
Status:
Active
Contact:
(434)981-4777
Total Funding:
0
Technology used in webpage:
Apache PHP SAKURA Internet
Similar Organizations
Chaperone Therapeutics
Chaperone Therapeutics is developing frontline therapies to address diseases of protein misfolding
Hygeia Therapeutics
Hygeia Therapeutics acquires and develops biodegradable hormone receptor modulators for topical indications.
Investors List
BlueTree Allied Angels
BlueTree Allied Angels investment in Seed Round - DiaKine Therapeutics
Official Site Inspections
http://www.diakine.com
- Host name: www31320u.sakura.ne.jp
- IP address: 49.212.47.114
- Location: Osaka Japan
- Latitude: 34.6848
- Longitude: 135.5142
- Timezone: Asia/Tokyo
- Postal: 543-0062
